Intro

Exploring Eli Lilly's recent purchase of Morphic, a company specializing in gastrointestinal health, with insights from Sam Vazelli, Bloomberg Intelligence's Director of Research for Global Industries and Pharmaceuticals.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app